DVS Sciences Citing Rise in Publications, Piper Jaffray Projects Solid Growth for Fluidigm CyTOF in 2015 According to the Piper Jaffray analysis, of the 54 total papers published using CyTOF technology, 25 of them, or 46 percent, were published in 2014. Fluidigm Q3 Revenues Grow 62 Percent NEW YORK (GenomeWeb) — Fluidigm said after the close of the market on Thursday that its third quarter revenues increased 62 percent year over year, or 35 percent organically. Fluidigm Q1 Revenues Rise 77 Percent on Instrument Sales NEW YORK (GenomeWeb News) – Fluidigm reported after the close of the market Monday that its first quarter revenues increased 77 percent year over year, driven by strong instrument sales as well as contributions from a recent acquisition. Stanford, Zurich Teams Develop Mass Spec-based Proteomics Technologies for Targeted Tissue Imaging Premium Two research teams have separately developed new imaging mass spec technologies for targeted protein measurements in tissue. Fluidigm Continues Move into Proteomics with $207.5M Acquisition of DVS Sciences Premium Fluidigm said this week that it has agreed to acquire mass cytometry firm DVS Sciences for roughly $207.5 million in company common stock and cash. Jan 29, 2014 Fluidigm to Purchase Mass Cytometry Firm DVS Sciences for $207M in Cash and Stock Sep 6, 2013 DTU Team Testing Orbitrap Fusion's Phosphoproteomic Capabilities as Part of Thermo Collaboration Premium May 10, 2013 New Products: DVS Sciences, Biognosys Premium Apr 26, 2013 Stanford Researchers Applying Multi-omics Approach to Profiling Immune Health Premium Jan 11, 2013 German Startup Zellkraftwerk Launches Chip Cytometry Service; Aims to Release Instrument this Fall Premium Aug 24, 2012 Nolan Lab Profiles Small-Molecule Inhibitors Using New Multiplexing Method for DVS Sciences' CyTOF Premium Jul 2, 2012 DVS Sciences, Cytobank Partner on Data Software for Mass Cytometry Jun 29, 2012 DVS Sciences Collaborating with Cytobank on Informatics Tools for CyTOF Platform Premium Dec 9, 2011 People in the News: Joseph Victor; Leroy Hood; and More Premium Jul 15, 2011 Pfizer, Roche Join $14.6M Financing for Mass Cytometry Startup DVS Sciences Premium Jul 14, 2011 DVS Sciences Raises $14.6M May 13, 2011 Stanford Team Uses DVS Sciences' CyTOF for Massive Hematopoietic Cell Protein Signaling Project Premium Mar 4, 2011 Q&A: University of Toronto's Scott Tanner on the Use of Atomic Mass Spectrometry in Proteomics Premium May 21, 2010 Univ. of Toronto Spinout Rolls Out New Biomarker System with Eye on Bead Array Market Apr 26, 2010 OICR Invests in Personalized Medicine Spin-offs Breaking News In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.